Treatment intensity and symptom burden in hospitalized adolescent and young adult hematopoietic cell transplant recipients at the end of life
Impact of choice, timing, sequence and combination of broadspectrum antibiotics on the outcome of allogeneic haematopoietic stem cell transplantation
Reduced-toxicity conditioning for allogeneic hematopoietic cell transplantation in elderly or comorbid patients with AML using fludarabine, BCNU and melphalan: disease stage at transplant determines outcome
Combined intensive immunosuppression and eculizumab for aplastic anemia in the context of hemolytic paroxysmal nocturnal hemoglobinuria: a retrospective analysis
Elevated pre-transplant C-reactive protein identifies a high-risk subgroup in multiple myeloma patients undergoing delayed autologous stem cell transplantation
Neurologic complications after allogeneic hematopoietic stem cell transplantation: risk factors and impact
Impact of HLA-G polymorphism on the outcome of allogeneic hematopoietic stem cell transplantation for metastatic renal cell carcinoma
Medication adherence among allogeneic hematopoietic stem cell transplant recipients: a pilot single-center study
Frailty: the missing piece of the pre- hematopoietic cell transplantation assessment?
High-dose BCNU/Melphalan conditioning regimen before autologous stem cell transplantation in newly diagnosed multiple myeloma
‘Real-life’ report on the management of chronic GvHD in the Gruppo Italiano Trapianto Midollo Osseo (GITMO)
Recommendations for reporting post-transplant relapse in AML
Myeloablative conditioning regimens with combined of haploidentical and cord blood transplantation for myelodysplastic syndrome patients
The kinetics of torque teno virus plasma DNA load shortly after engraftment predicts the risk of high-level CMV DNAemia in allogeneic hematopoietic stem cell transplant recipients
Role of thymoglobulin in matched sibling allogeneic hematopoietic stem cell transplantation with busulfan and fludarabine conditioning in myeloid malignanicies
Foiling fungal disease post hematopoietic cell transplant: review of prophylactic strategies
Correlation between pediatric donor characteristics and cell compositions in mixture allografts of combined G-CSF-mobilized PBSCs and bone marrow allografts
Viral-specific T-cell transfer from HSCT donor for the treatment of viral infections or diseases after HSCT
NSAID treatment with meloxicam enhances peripheral stem cell mobilization in myeloma
Donor and recipient plasma follistatin levels are associated with acute GvHD in Blood and Marrow Transplant Clinical Trials Network 0402
Transbronchial biopsy in the management of pulmonary complications of hematopoietic stem cell transplantation
Donor-lymphocyte infusion following haploidentical hematopoietic cell transplantation with peripheral blood stem cell grafts and PTCy
Replacing carmustine by thiotepa and cyclophosphamide for autologous stem cell transplantation in Hodgkin's and non-Hodgkin's B-cell lymphoma
Risks factors and timing of genital human papillomavirus (HPV) infection in female stem cell transplant survivors: a longitudinal study
Engender trust and edify
Successful correction of familial hemophagocytic lymphohistiocytosis using prenatal genetic testing and preemptive hematopoietic stem cell transplantation
Infusion of autograft natural killer cell/CD14+HLA-DRDIM cell ratio predicts survival in lymphoma post autologous stem cell transplantation
Long-term outcome of mixed chimerism after stem cell transplantation for thalassemia major conditioned with busulfan and cyclophosphamide
Long-term prognosis for 1-year relapse-free survivors of CD34+ cell-selected allogeneic hematopoietic stem cell transplantation: a landmark analysis
Lack of association between relationship status and clinical outcome in allogeneic stem cell transplantation—the Swiss Transplant Cohort Study
Importance of conditioning regimen intensity, MRD positivity, and KIR ligand mismatch in UCB transplantation
Population pharmacokinetics and pharmacodynamics of mycophenolic acid using the prospective data in patients undergoing hematopoietic stem cell transplantation
Secondary solid cancer following hematopoietic cell transplantation in patients with thalassemia major
Allogeneic stem cell transplantation for non-de novo AML or advanced myelodysplastic syndromes: influence of GvHD and donor lymphocyte infusions on long-term outcome
Assessment of TREC, KREC and telomere length in long-term survivors after allogeneic HSCT: the role of GvHD and graft source and evidence for telomere homeostasis in young recipients
Third International workshop on the biology, prevention, and treatment of relapse after stem cell transplantation
Donor cell-derived transient abnormal myelopoiesis as a specific complication of umbilical cord blood transplantation
Early consolidation with high-dose therapy and autologous stem cell transplantation is a feasible and effective treatment option in HIV-associated non-Hodgkin lymphoma at high risk
Post-autologous transplant maintenance therapies in lymphoma: current state and future directions
Associations between acute gastrointestinal GvHD and the baseline gut microbiota of allogeneic hematopoietic stem cell transplant recipients and donors
Donor T-cell responses and disease progression patterns of multiple myeloma
Modified BEAM as conditioning regimen for lymphoma patients undergoing autologous hematopoietic stem cell transplantation
Hematopoietic stem cell transplant-associated thrombotic microangiopathy: current paradigm and novel therapies
Potential niche indications for blinatumomab as a bridge to hematopoietic cell transplantation
Impact of a dedicated post-transplant vaccination service at an Australian cancer centre
Autologous hematopoietic cell transplantation for multiple myeloma patients with renal insufficiency: a center for international blood and marrow transplant research analysis
The capacity-building approach was successful in the start-up process of the first HSCT center in Iraqi Kurdistan
Allogeneic stem cell transplantation and subsequent treatments as a comprehensive strategy for long-term survival of multiple myeloma patients
Depression and anxiety following hematopoietic stem cell transplantation: a prospective population-based study in Germany
Circulating endothelial cell count: a reliable marker of endothelial damage in patients undergoing hematopoietic stem cell transplantation
A phase 1 trial of 90Y-Zevalin radioimmunotherapy with autologous stem cell transplant for multiple myeloma
Impact of cigarette smoking on survival after myeloablative allogeneic hematopoietic stem cell transplantation and contribution of invasive fungal infection
αβ-T-cell depleted donor lymphocyte infusion for leukemia relapse after allogeneic stem cell transplantation
Acute and fatal cardiotoxicity following high-dose cyclophosphamide in a patient undergoing autologous stem cell transplantation for systemic sclerosis despite satisfactory cardiopulmonary screening
Successful bone marrow transplantation in two sisters with activated phosphoinositide 3-kinase δ syndrome 2
Thrombotic microangiopathy associated with monoclonal gammopathy following autologous hematopoietic stem cell transplantation for neuroblastoma in a young child
Multiple myeloma with extramedullary disease: impact of autologous stem cell transplantation on outcome
Association between GvHD and nivolumab in the FDA adverse event reporting system
Higher rates of relapse in maternal recipients of haploidentical hematopoietic stem cell transplantation from adult offspring donors for AML and myelodysplastic syndrome
Diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in pediatric patients: a new classification from the European society for blood and marrow transplantation
Therapeutic salivary monitoring of IV busulfan in patients undergoing hematopoietic stem cell transplantation: a pilot study
Fertility preservation issues in pediatric hematopoietic stem cell transplantation: practical approaches from the consensus of the Pediatric Diseases Working Party of the EBMT and the International BFM Study Group
Outcomes of salvage autologous stem cell transplantation for multiple myeloma with cytopenias and exposure to novel agents
Faecal microbiota transplant: a novel biological approach to extensively drug-resistant organism-related non-relapse mortality
Dengue encephalitis in allogenic hematopoietic stem cell transplantation recipient
Impact of the presence of HLA 1-locus mismatch and the use of low-dose antithymocyte globulin in unrelated bone marrow transplantation
Long-term systolic function in children and young adults after hematopoietic stem cell transplant
Early hepatitis E infection in an unrelated hematopoietic progenitor stem cell donor
Trust, not education, is the key to consent in hematopoietic cell transplant: in response to D'Souza, Pasquini and Spellecy
Association between single nucleotide polymorphisms of tumor necrosis factor gene and grade II-IV acute GvHD: a systematic review and meta-analysis
Cerebral adenovirus endotheliitis presenting as posterior reversible encephalopathy syndrome after allogeneic stem cell transplantation
Gender differences in physical function and muscle mass change in patients undergoing allogeneic hematopoietic stem cell transplantation
Analysis of hematopoietic recovery after autologous transplantation as method of quality control for long-term progenitor cell cryopreservation
Inability to work and need for disability pension among long-term survivors of hematopoietic stem cell transplantation
Transplant-associated thrombotic microangiopathy is an endothelial complication associated with refractoriness of acute GvHD
Regional intra-arterial steroid treatment in 120 patients with steroid-resistant or -dependent GvHD
Clinical impact of NK-cell reconstitution after reduced intensity conditioned unrelated cord blood transplantation in patients with acute myeloid leukemia: analysis of a prospective phase II multicenter trial on behalf of the Société Française de Greffe de Moelle Osseuse et Thérapie Cellulaire and Eurocord
Against the odds: haplo-cord grafts protect from GvHD and relapse
When should preemptive antiviral therapy for active CMV infection be withdrawn from allogeneic stem cell transplant recipients?
The evolving role of chemotherapy and hematopoietic cell transplants in Ph-positive acute lymphoblastic leukemia in adults
A phase I/II minor histocompatibility antigen-loaded dendritic cell vaccination trial to safely improve the efficacy of donor lymphocyte infusions in myeloma
Evolving concepts in prognostic scoring of chronic GvHD
JACIE accreditation for blood and marrow transplantation: past, present and future directions of an international model for healthcare quality improvement
Bacterial bloodstream infections in the allogeneic hematopoietic cell transplant patient: new considerations for a persistent nemesis
Transplant-associated thrombotic microangiopathy: opening Pandora's box
Early evaluation of immune reconstitution following allogeneic CD3/CD19-depleted grafts from alternative donors in childhood acute leukemia
Effects of Azithromycin in bronchiolitis obliterans syndrome after hematopoietic SCT—a randomized double-blinded placebo-controlled study
Regulation of donor participation in research studies : is there another way?
The great debate: haploidentical or cord blood transplant
Enshrining donor rights and optimizing patient outcome in unrelated donor transplantation
Unrelated hematopoietic stem cell donors as research subjects
Reduced-intensity SCT for chronic active EBV infection: excellent outcomes should trigger future investigations on how EBV-positive recipient cells are eradicated
Incidence and severity of oral mucositis in patients undergoing haematopoietic SCT (HSCT)-results of a multicentre study
What is the minimum level of donor chimerism necessary to sustain transfusion independence in thalassaemia?
Screening, prevention and management of osteoporosis and bone loss in adult and pediatric hematopoietic cell transplant recipients
Early clinical indicators of transplant-associated thrombotic microangiopathy in pediatric neuroblastoma patients undergoing auto-SCT
Mycobacterial diseases in pediatric hematopoietic SCT recipients
Clinical efficacy and safety of primary antifungal prophylaxis with posaconazole vs itraconazole in allogeneic blood and marrow transplantation
Prospective comparison of PCR-based vs late mRNA-based preemptive antiviral therapy for HCMV infection in patients after allo-SCT
Extracorporeal photopheresis in patients with refractory bronchiolitis obliterans developing after allo-SCT
Regulatory T cell expression of CLA or α4β7 and skin or gut acute GVHD outcomes
The addition of plerixafor is safe and allows adequate PBSC collection in multiple myeloma and lymphoma patients poor mobilizers after chemotherapy and G-CSF
Air-leak syndrome following allo-SCT in adult patients: report from the Kanto Study Group for Cell Therapy in Japan
Impact of high-dose chemotherapy followed by auto-SCT for positive interim [18F] FDG-PET diffuse large B-cell lymphoma patients
Assignment of scores for the hematopoietic cell transplantation comorbidity index: integer vs exact weights
Relationship between TNFA, TNFB and TNFRII gene polymorphisms and outcome after unrelated hematopoietic cell transplantation in a Chinese population
Order of application and liver toxicity in patients given BU and CY containing conditioning regimens for allogeneic hematopoietic SCT
The Mexican Way: a feasible approach to avoid DMSO toxicity
Prognostic factors in allo-SCT of elderly patients with AML
Long-term remission in pediatric Wegener granulomatosis following allo-SCT after reduced-intensity conditioning
World Marrow Donor Association framework for the implementation of HLA matching programs in hematopoietic stem cell donor registries and cord blood banks
Pandemic in.uenza A H1N1/09 virus infection in hematopoietic SCT recipient
Impact of the European Clinical Trials Directive on prospective academic clinical trials associated with BMT
Use of intrathecal chemoprophylaxis in children after SCT and the risk of central nervous system relapse
High probability of long-term survival in 2-year survivors of autologous hematopoietic cell transplantation for AML in first or second CR
Drug interaction between voriconazole and tacrolimus in allogeneic hematopoietic SCT recipients
Factors affecting mortality following myeloablative cord blood transplantation in adults : a pooled analysis of three international registries
Priming with r-metHuSCF and filgrastim or chemotherapy and filgrastim in patients with malignant lymphomas : a randomized phase II pilot study of mobilization and engraftment
Stem cell collection in patients with multiple myeloma : impact of induction therapy and mobilization regimen
Comparative analysis of BU and CY versus CY and TBI in full intensity unrelated marrow donor transplantation for AML, CML and myelodysplasia
Long-term outcomes after hematopoietic SCT for adult T-cell leukemia/lymphoma: results of prospective trials
High fludarabine exposure and relationship with treatment-related mortality after nonmyeloablative hematopoietic cell transplantation
Serum ferritin and disease status at transplantation predict the outcome of allo-SCT in patients with AML or myelodysplastic syndrome
Engraftment syndrome, but not acute GVHD, younger age, CYP3A5 or MDR1 polymorphisms, increases tacrolimus clearance in pediatric hematopoietic SCT
Disease-specific hematopoietic cell transplantation : nonmyeloablative conditioning regimen for dyskeratosis congenita
H1N1 infection mimicking the clinical presentation of gastrointestinal GVHD in a patient following allo-SCT
Successful prevention of respiratory syncytial virus nosocomial transmission following an enhanced seasonal infection control program
Risk of hepatitis B surface antigen seroreversion after allogeneic hematopoietic SCT
Feasibility of BU, CY and etoposide (BUCYE), and auto-SCT in patients with newly diagnosed primary CNS lymphoma : a single-center experience
Long-term outcome of patients with monoclonal Ig deposition disease treated with high-dose melphalan and stem cell transplantation
Therapy of steroid-refractory acute GVHD with CD52 antibody alemtuzumab is effective
Plerixafor plus granulocyte CSF can mobilize hematopoietic stem cells from multiple myeloma and lymphoma patients failing previous mobilization attempts: EU compassionate use data
Safety and efficacy of targeted busulfan therapy in children undergoing myeloablative matched sibling donor BMT for sickle cell disease
Observational prospective study of viral infections in children undergoing allogeneic hematopoietic cell transplantation : a 3-year GETMON experience
Comparison of donor chimerism following myeloablative and nonmyeloablative allogeneic hematopoietic SCT
Delayed neutrophil engraftment in cord blood transplantation with intensive administration of mycophenolate mofetil for GVHD prophylaxis
Unrelated hematopoietic stem cell donors as research subjects
Caspofungin first-line therapy for invasive aspergillosis in allogeneic hematopoietic stem cell transplant patients: an European Organisation for Research and Treatment of Cancer study
Excessive toxicity of once daily i.v. BU, melphalan and thiotepa followed by auto SCT on patients with non-Hodgkin's lymphoma
Assessment of CD4 T-lymphocyte reactivity by the Cylex ImmuKnow assay in patients following allogeneic hematopoietic SCT
Allogeneic hemopoietic SCT for patients with primary myelo.brosis: a predictive transplant score based on transfusion requirement, spleen size and donor type
MSC for the improvement of hematopoietic engraftment
Adopting autologous hematopoietic stem cells with non-functional CCR5 and CXCR4 against HIV
Absence of IL-23p19 in donor allogeneic cells reduces mortality from acute GVHD
The impact of a change in antibacterial prophylaxis from ceftazidime to levofloxacin in allogeneic hematopoietic cell transplantation
Successful treatment of sinusoidal obstructive syndrome after hematopoietic stem cell transplantation with recombinant human soluble thrombomodulin
Prophylaxis with mycophenolate mofetil and CsA can decrease the incidence of severe acute GVHD after antithymocyte globulin-based reduced-intensity preparative regimen and allo-SCT from HLA-matched unrelated donors
Diffuse alveolar hemorrhage after unrelated cord blood transplantation
Sequential Organ Failure Assessment predicts the outcome of SCT recipients admitted to intensive care unit
Suboptimal long-term physical performance in children and young adults after pediatric allo-SCT
Efficacy of a 3-day, low-dose treatment with 5-azacytidine followed by donor lymphocyte infusions in older patients with acute myeloid leukemia or chronic myelomonocytic leukemia relapsed after allografting
IL-21 is critical for GVHD in a mouse model
The quality of life of adult survivors of childhood hematopoietic cell transplant
Efficacy of lenalidomide in an sAML patient with del 5q relapsing after reduced-intensity allogeneic stem cell transplantation performed in complete remission
Long-term remission after CD34+-selected PBSCT in a patient with advanced intra-abdominal desmoplastic small round-cell tumor
Early thrombin generation and impaired fibrinolysis after SCT associate with acute GVHD
Successful allogeneic bone marrow transplantation for chronic myelomonocytic leukemia complicated by refractory aortitis
Comparison of thrombotic microangiopathy after allogeneic hematopoietic cell transplantation with high-dose or nonmyeloablative conditioning
Thrombocytopenia and hemostatic disorders in chronic graft versus host disease
Allogeneic hematopoietic stem cell transplantation for acquired aplastic anemia using cyclophosphamide and antithymocyte globulin: a single center experience